Article Text

Licensing agreement to develop a new mastitis vaccine

Statistics from

PHARMACEUTICAL company Bayer has entered a licensing agreement with a Canadian university to take forward a novel vaccine candidate to help protect dairy cattle from mastitis caused by Staphylococcus aureus.

The novel vaccine candidate was discovered at the Université de Sherbrooke in Quebec. As part of the licensing agreement, Bayer will develop …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.